We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production.AuthorsR. J. Pepper; M. A. Fabre; C. Pavesio; G. Gaskin; R. B. Jones; D. Jayne; C. D. Pusey; A. D. SalamaPublicationRheumatology, 2008, Vol 47, Issue 7, p1104ISSN1462-0324Publication typeAcademic JournalDOI10.1093/rheumatology/ken175